Biological evaluation of alginate-based hydrogels, with antimicrobial features by Ce(III) incorporation, as vehicles for a bone substitute

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 9, 2013, Pages 2145-2155

  Morais, D S ^a   Rodrigues, M A ^b   Lopes, M A ^b   Coelho, M J ^c   Mauricio A C ^b   Gomes, R ^b   Amorim, I ^b   Ferraz, M P ^c   Santos, J D ^b   Botelho, C M ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTI-MICROBIAL PROPERTIES; ANTIMICROBIAL ABILITY; BIOLOGICAL EVALUATION; EXTRACELLULAR MATRICES; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ALGINATE; BACTERIA; BONE; CELLS; CYTOLOGY; ENZYME INHIBITION; IONS; MIXTURES; REPAIR; TISSUE;

HYDROGELS;

ALGINIC ACID; ALSIR; CERIUM; CHITOSAN; ENROFLOXACIN; EUTHASIL; HYALURONIC ACID; IMALGENE 1000; PHARMACEUTICAL VEHICLES AND ADDITIVES; UNCLASSIFIED DRUG; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BONE CONDUCTION; BONE PROSTHESIS; BONE REGENERATION; CANDIDA ALBICANS; CELL SHAPE; CELL VIABILITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG SYNTHESIS; EXTRACELLULAR MATRIX; FILOPODIUM; HUMAN; HUMAN CELL; HYDROGEL; MALE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TISSUE REPAIR;

ANIMALIA; CANDIDA ALBICANS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ALGINATES; ANIMALS; ANTI-INFECTIVE AGENTS; BONE SUBSTITUTES; CELL LINE, TUMOR; CERIUM; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGELS; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84884283812     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4971-9     Document Type: Article

References (52)

1. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36:20-7.
2. Bostrom MPG, Seigerman DA. The clinical use of allografts, demineralized bone matrices, synthetic bone graft substitutes and osteoinductive growth factors: a survey study. HSS J. 2005;1:9-18.
3. Lopes MA, Knowles JC, Santos JD. Structural insights of glass-reinforced hydroxyapatite composites by rietveld refinement. Biomaterials. 2000;21:1905-10.
4. ® for orthopaedic applications. Acta Biomat. 2008;4:370-7.
5. 5 glass reinforced-hydroxyapatite composites on the growth and function of osteoblast-like cells. Biomaterials. 2000;21:1165-72.
6. Liu H, Li H, Cheng W, Yang Y, Zhu M, Zhou C. Novel injectable calcium phosphate/chitosan composites for bone substitute materials. Acta Biomat. 2006;2(5):557-65.
7. Larsson S, Hannink G. Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments. Injury. 2011;42:30-4.
8. Martínez-Sanz E, Ossipov DA, Hilborn J, Larsson S, Jonsson KB, Varghese OP. Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. J Control Release. 2011;152:232-40.
9. Gaharwar AK, Dammu SA, Canter JM, Wu C, Schmidt G. Highly extensible, tough, and elastomeric nanocomposite hydrogels from poly(ethylene glycol) and hydroxyapatite nanoparticles. Biomacromolecules. 2011;12:1641-50.
10. Oliveira SM, Almeida IF, Costa PC, Barrias CC, Ferreira MRP, Bahia MF, et al. Characterization of polymeric solutions as injectable vehicles for hydroxyapatite microspheres. AAPS PharmSciTech. 2010;11:852-8.
11. Couto D, Hong Z, Mano J. Development of bioactive and biodegradable chitosan-based injectable systems containing bioactive glass nanoparticles. Acta Biomat. 2009;5:115-23.
12. Vaccaro AR. The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics. 2002;25:571-8.
13. Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS, et al. Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface. 2007;4:999-1030.
14. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA. Hydrogels in regenerative medicine. Adv Mater. 2009;21:3307-29.
15. Wang L, Shelton RM, Cooper PR, Lawson M, Triffitt JT, Barralet JE. Evaluation of sodium alginate for bone marrow cell tissue engineering. Biomaterials. 2003;24:3475-81.
16. West E, Xu M, Woodruff T, Shea L. Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials. 2007;28:4439-48.
17. Sriamornsak P, Thirawong N, Korkerd K. Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm. 2007;66:435-50.
18. Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci B. 2011;49:832-64.
19. Andersen T, Strand BL, Formo K, Alsberg E, Christensen BE. Alginates as biomaterials in tissue engineering. J Carbohydr Chem. 2012;37:227-58.
20. Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci. 2007;32:762-98.
21. Chen A, Haddad D, Wang R. Analysis of chitosan-alginate bone scaffolds. Newark: New Jersey Governor's School of Engineering & Technology; 2009. p. 1-8.
22. Aranaz I, Mengíbar M, Harris R, Paños I, Miralles B, Acosta N, et al. Functional characterization of chitin and chitosan. Curr Chem Biol. 2009;3:203-30.
23. Brown MB, Jones SA. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol. 2005;19:308-18.
24. Prestwich GD. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release. 2011;155:193-9.
25. Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, et al. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials. 2007;28:1830-7.
26. Patterson J, Siew R, Herring SW, Lin ASP, Guldberg R, Stayton PS. Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials. 2010;31:6772-81.
27. Martínez-Sanz E, Ossipov DA, Hilborn J, Larsson S, Jonsson KB, Varghese OP. Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. J Control Release. 2011;152:232-40.
28. Nagaoka I, Igarashi M, Sakamoto K. Biological activities of glucosamine and its related substances. Adv Food Nutr Res. 2012;65:337-52.
29. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials. 2006;27:2331-9.
30. Campoccia D, Montanaro L, Speziale P, Arciola CR. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials. 2010;31:6363-77.
31. Cobrado L, Azevedo MM, Silva-Dias A, Ramos JP, Pina-Vaz C, Rodrigues AG. Cerium, chitosan and hamamelitannin as novel biofilm inhibitors? J Antimicrob Chemoth. 2012;67:1159-62.
32. Garner JP, Heppell PSJ. Cerium nitrate in the management of burns. Burns. 2005;31:539-47.
33. Zhang H, Feng J, Zhu W, Liu C, Gu J. Bacteriostatic effects of cerium-humic acid complex. Biol Trace Elem Res. 1999;73:29-36.
34. Morais DS, Rodrigues MA, Silva TI, Lopes MA, Santos M, Santos JD, Botelho CM. Development and characterization of novel alginate-based hydrogels as vehicles for bone substitutes. Carbohydr Polym. 2013;95(1):134-42.
35. Takahashi S, Abe T, Gotoh J, Fukuuchi Y. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochem Int. 2002;40(5):441-8.
36. Dee KC, Puleo DA, Bizios R, editors. An introduction to tissue-biomaterial interactions. New York: Wiley; 2002.
37. Hempel U, Hefti T, Dieter P, Schlottig F. Response of human bone marrow stromal cells, MG-63, and SaOS-2 to titanium-based dental implant surfaces with different topography and surface energy. Clin Oral Implants Res. 2011;24(2):1-9.
38. Chunga TW, Yangb J, Akaikeb T, Choc KY, Nahd JW, Kima SI, et al. Preparation of alginate/galactosylated chitosan scaffold. Biomaterials. 2001;23:2827-34.
39. Zaleski KJ, Kolodka T, Cywes-Bentley C, McLoughlin RM, Delaney ML, Charlton BT, et al. Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection. Antimicrob Agents Chemother. 2006;50:3856-60.
40. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials. 2000;21(7):667-81.
41. Wutticharoenmongkol P, Pavasant P, Supaphol P. Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles. Biomacromolecules. 2007;8:2602-10.
42. Gwynn IA. Cell biology at interfaces. J Mater Sci Mater Med. 1994;5:357-60.
43. 4-bioglass composites stimulate the proliferation of MG63 osteoblast-like cells and support the osteogenic differentiation of human bone marrow cells. Biomaterials. 2002;23(24):4897-906.
44. Yang D, Lü X, Hong Y, Xi T, Zhang D. The molecular mechanism of mediation of adsorbed serum proteins to endothelial cells adhesion and growth on biomaterials. Biomaterials. 2013;34:5747-58.
45. Carlson GA, Dragoo JL, Samimi B, Bruckner DA, Bernard GW, Hedrick M, et al. Bacteriostatic properties of biomatrices against common orthopaedic pathogens. Biochem Biophys Res Commun. 2004;321:472-8.
46. Lima R, Seabra AB, Durán N. Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol. 2012;32:867-79.
47. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria reply. New Engl J Med. 2010;363:1483-4.
48. Diba K, Rhaimirad M, Makhdoomi K, Khorshidvand Z. Identification of Candida species isolated from hospital acquired infections cases and hospital indoor environments. Afr J Microbiol Res. 2012;6:4164-8.
49. Palffy R, Gardlik R, Behuliak M, Kadasi L, Turna J, Celec P. On the physiology and pathophysiology of antimicrobial peptides. Mol Med. 2009;15:51-9.
50. Gariboldi S, Palazzo M, Zanobbio L, Selleri S, Sommariva M, Sfondrini L, et al. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol. 2008;181:2103-10.
51. Amara SG, Gudermann T, Jahn R, Lill R, Nilius B, Offermanns S, et al., editors. Reviews of physiology, biochemistry and pharmacology. Netherlands: Springer; 2005.
52. Jakupec MA, Unfried P, Keppler BK. Pharmacological properties of cerium compounds. Rev Physiol Biochem Pharmacol. 2005;153:101-11.